1 Bray F,Laversanne M,Weiderpass E,et al.The ever-increasing importance of cancer as a leading cause of premature death worldwide[J].Cancer,2021,127(16):3029-3030. 2 Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249. 3 Xia C,Dong X,Li H,et al.Cancer statistics in China and United States,2022:profiles,trends,and determinants[J].Chin Med J(Engl),2022,135(5):584-590. 4 李娟,刘家仁.胃癌免疫治疗的研究现状及进展[J].实用肿瘤学杂志,2023,37(4):372-376. 5 Pilotto Heming C,Muriithi W,Wanjiku Macharia L,et al.P-glycoprotein and cancer:what do we currently know?[J].Heliyon,2022,8(10):e11171. 6 Lin KN,Jiang YL,Zhang SG,et al.Grape seed proanthocyanidin extract reverses multidrug resistance in HL-60/ADR cells via inhibition of the PI3K/Akt signaling pathway[J].Biomed Pharmacother,2020,125:109885. 7 Huang R,Zhou PK.DNA damage repair:historical perspectives,mechanistic pathways and clinical translation for targeted cancer therapy[J].Signal Transduct Target Ther,2021,6(1):254. 8 Chen Y,Wu J,Zhai L,et al.Metabolic regulation of homologous recombination repair by MRE11 lactylation[J].Cell,2023,187(2):294-311. 9 Xu G,Shi Y.Apoptosis signaling pathways and lymphocyte homeostasis[J].Cell Res,2007,17(9):759-771. 10 Elmore S.Apoptosis:a review of programmed cell death[J].Toxicol Pathol,2007,35(4):495-516. 11 Kalkavan H,Chen MJ,Crawford JC,et al.Sublethal cytochrome c release generates drug-tolerant persister cells[J].Cell,2022,185(18):3356-3374. 12 Bird A.DNA methylation patterns and epigenetic memory[J].Genes Dev,2002,16(1):6-21. 13 Okugawa Y,Grady WM,Goel A.Epigenetic alterations in colorectal cancer:emerging Biomarkers[J].Gastroenterology,2015,149(5):1204-1225. 14 Moore LD,Le T,Fan G.DNA methylation and its basic function[J].Neuropsychopharmacology,2013,38(1):23-38. 15 Taby R,Issa JP.Cancer epigenetics[J].CA Cancer J Clin,2010,60(6):376-392. 16 Romero-Garcia S,Prado-Garcia H,Carlos-Reyes A.Role of DNA methylation in the resistance to therapy in solid tumors[J].Front Oncol,2020,10:1152. 17 黄剑,庞慧,宋雨航.microRNA在乳腺癌耐药中的作用[J].实用肿瘤学杂志,2017,31(3):272-276. 18 Valeri N,Gasparini P,Braconi C,et al.MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2(hMSH2)[J].Proc Natl Acad Sci U S A,2010,107(49):21098-21103. 19 Liang G,Zhu Y,Ali DJ,et al.Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer[J].J Nanobiotechnology,2020,18(1):10. 20 Dixon SJ,Lemberg KM,Lamprecht MR,et al.Ferroptosis:an iron-dependent form of nonapoptotic cell death[J].Cell,2012,149(5):1060-1072. 21 Li J,Cao F,Yin HL,et al.Ferroptosis:past,present and future[J].Cell Death Dis,2020,11(2):88. 22 Du J,Wang X,Li Y,et al.DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism[J].Cell Death Dis,2021,12(7):705-719. 23 Reinhold WC,Sunshine M,Liu H,et al.CellMiner:a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set[J].Cancer Res,2012,72(14):3499-3511. 24 Dai E,Wang J,Yang F,et al.Accurate prediction and elucidation of drug resistance based on the robust and reproducible chemoresponse communities[J].Int J Cancer,2018,142(7):1427-1439. 25 Barretina J,Caponigro G,Stransky N,et al.The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity[J].Nature,2012,483(7391):603-607. 26 Yang W,Soares J,Greninger P,et al.Genomics of Drug Sensitivity in Cancer(GDSC):a resource for therapeutic biomarker discovery in cancer cells[J].Nucleic Acids Res,2013,41(Database issue):955-961. 27 Liu H,Wang S,Zhou S,et al.Drug resistance-related competing interactions of lncRNA and mRNA across 19 Cancer Types[J].Mol Ther Nucleic Acids,2019,16:442-451. 28 Tomczak K,Czerwińska P,Wiznerowicz M.The Cancer Genome Atlas(TCGA):an immeasurable source of knowledge[J].Contemp Oncol(Pozn),2015,19(1a):68-77. 29 Zhou X,Mitra R,Hou F,et al.Genomic landscape and potential regulation of RNA editing in drug resistance[J].Adv Sci(Weinh),2023,10(14):e2207357. 30 Dai E,Yang F,Wang J,et al.ncDR:a comprehensive resource of non-coding RNAs involved in drug resistance[J].Bioinformatics,2017,33(24):4010-4011. 31 Li L,Wu P,Wang Z,et al.NoncoRNA:a database of experimentally supported non-coding RNAs and drug targets in cancer[J].J Hematol Oncol,2020,13(1):15. 32 Zhang N,Wang H,Fang Y,et al.Predicting anticancer drug responses using a dual-layer integrated cell line-drug network model[J].PLoS Comput Biol,2015,11(9):e1004498. 33 Schneider A,Hommel G,Blettner M.Linear regression analysis:part 14 of a series on evaluation of scientific publications[J].Dtsch Arztebl Int,2010,107(44):776-782. 34 Wang Y,Wang Z,Xu J,et al.Systematic identification of non-coding pharmacogenomic landscape in cancer[J].Nat Commun,2018,9(1):3192. 35 Breiman L.Random Forests[J].Machine Learning,2001,45(1):5-32. 36 Rahman R,Matlock K,Ghosh S,et al.Heterogeneity aware random forest for drug sensitivity prediction[J].Sci Rep,2017,7(1):11347. 37 Baptista D,Ferreira PG,Rocha M.Deep learning for drug response prediction in cancer[J].Brief Bioinform,2021,22(1):360-379. 38 Kuenzi BM,Park J,Fong SH,et al.Predicting drug response and synergy using a deep learning model of human cancer cells[J].Cancer Cell,2020,38(5):672-684. 39 Li M,Wang Y,Zheng R,et al.DeepDSC:A Deep learning method to predict drug sensitivity of cancer cell lines[J].IEEE/ACM Trans Comput Biol Bioinform,2021,18(2):575-582. 40 Wang H,Dai C,Wen Y,et al.GADRP:graph convolutional networks and autoencoders for cancer drug response prediction[J].Brief Bioinform,2023,24(1):501. 41 Chen J,Wang X,Ma A,et al.Deep transfer learning of cancer drug responses by integrating bulk and single-cell RNA-seq data[J].Nat Commun,2022,13(1):6494. |